Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions

American Journal of Pathology

Volumn 175, Issue 1, 2009, Pages 283-293

  Weinger, Jason G ^a   Omari, Kakuri M ^a   Marsden, Kurt ^a   Raine, Cedric S ^a   Shafit Zagardo, Bridget ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXL TYROSINE KINASE; BETA ACTIN; BETA TUBULIN; FURIN; GROWTH ARREST SPECIFIC PROTEIN 6; MEMBRANE RECEPTOR; MER RECEPTOR TYROSINE KINASE; PROTEIN ADAM10; PROTEIN TYRO3; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN HOMOGENATE; CELL GROWTH; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOLUBILIZATION; UPREGULATION;

EID: 67649935007     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080807     Document Type: Article

References (66)

1. Sospedra M, Martin R: Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938-952
3. Fontoura P, Steinman L, Miller A: Emerging therapeutic targets in multiple sclerosis. Curr Opin Neurol 2006, 19:260-266
4. Frohman EM, Racke MK, Raine CS: Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 2006, 354:942-955
5. Raine CS: The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 1997, 77:135-152
6. Franklin RJ: Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002, 3:705-714
7. Prieto AL, Weber JL, Lai C: Expression of the receptor protein-tyrosine kinases Tyro-3. Axl, and mer in the developing rat central nervous system. J Comp Neurol 2000, 425:295-314
8. Stitt TN, Conn G, Gore M, Lai C, Bruno J, Radziejewski C, Mattsson K, Fisher J, Gies DR, Jones PF, Masiakowski P, Ryan TE, Tobkes NJ, Chen DH, DiStefano PS, Long GL, Basilico C, Goldfarb MP, Lemke G, Glass DL and Yancopoulos GD: The anticoagulation factor protein S and its relative: Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995, 80:661-670
9. Avanzi GC, Gallicchio M, Bottarel F, Gammaitoni L, Cavalloni G, Buonfiglio D, Bragardo M, Bellomo G, Albano E, Fantozzi R, Garbarino G, Varnum B, Aglietta M, Saglio G, Dianzani U, Dianzani C: GAS6 inhibits granulocyte adhesion to endothelial cells. Blood 1998, 91:2334-2340
10. Allen MP, Zeng C, Schneider K, Xiong X, Meintzer MK, Bellosta P, Basilico C, Varnum B, Heidenreich KA, Wierman ME: Growth arrestspecific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol 1999, 13:191-201
11. Varnum BC, Young C, Elliott G, Garcia A, Bartley TD, Fridell YW, Hunt RW, Trail G, Clogston C, Toso RJ, Yanagihara D, Bennet L, Sylber M, Merewether LA, Tseng A, Escobar E, Liu ET, Yamane HK: Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 1995,373:623-626
12. Manfioletti G, Brancolini C, Avanzi G, Schneider C: The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993,13:4976-4985
13. Godowski PJ, Mark MR, Chen J, Sadick MD, Raab H, Hammonds RG: Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 1995, 82:355-358
14. Chen J, Carey K, Godowski PJ: Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 1997, 14:2033-2039
15. Nagata K, Ohashi K, Nakano T, Arita H, Zong C, Hanafusa H, Mizuno K: Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl. Sky, and Mer receptor tyrosine kinases. J Biol Chem 1996, 271:30022-30027
16. Bellosta P, Costa M, Lin DA, Basilico C: The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding. Mol Cell Biol 1995, 15:614-625
17. Heiring C, Dahlback B, Muller YA: Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family. J Biol Chem 2004, 279:6952-6958
18. Goruppi S, Ruaro E, Varnum B, Schneider C: Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene 1999, 18:4224-4236
19. Shankar SL, O'Guin K, Cammer M, McMorris FA, Stitt TN, Basch RS, Varnum B, Shafit-Zagardo B: The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. J Neurosci 2003, 23:4208-4218
20. Weinger JG, Gohari P, Yan Y, Backer JM, Varnum B, Shafit-Zagardo B: In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation. J Neurochem 2008, 106:134-146
21. Shankar SL, O'Guin K, Kim M, Varnum B, Lemke G, Brosnan CF, Shafit-Zagardo B: Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis. J Neurosci 2006, 26:5638
22. Budagian V, Bulanova E, Orinska Z, Thon L, Mamat U, Bellosta P, Basilico C, Adam D, Paus R, Bulfone-Paus S: A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J 2005, 24:4260-4270
23. Sharief MK, Hentges R: Association between tumor necrosis factoralpha and disease progression in patients with multiple sclerosis. N Engl J Med 1991, 325:467-472
24. Bertolotto A, Malucchi S, Capobianco M, Manzardo E, Guastamacchia G, Milano E, Audano L, Mutani R: Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. J Interferon Cytokine Res 1999, 19:575-581
25. Perez C, Albert I, Defay K, Zachariades N, Gooding L, Kriegler M: A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 1990, 63:251-258
26. Utsumi T, Levitan A, Hung MC, Klostergaard J: Effects of truncation of human pro-tumor necrosis factor transmembrane domain on cellular targeting. J Biol Chem 1993, 268:9511-9516
27. Moss ML, Jin SL, Becherer JD, Bickett DM, Burkhart W, Chen WJ, Hassler D, Leesnitzer MT, McGeehan G, Milla M, Moyer M, Rocque W, Seaton T, Schoenen F, Warner J, Willard D: Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). J Neuroimmunol 1997, 72:127-129
28. Talhouk RS, Bissell MJ, Werb Z: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992,118:1271-1282
29. Jeffrey JJ: Collagen and collagenase: pregnancy and parturition. Semin Perinatol 1991, 15:118-126
30. Salamonsen LA: Matrix metalloproteinases and endometrial remodelling. Cell Biol Int 1994, 18:1139-1144
31. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr: Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993, 7:1434-1441
32. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-573
33. Gijbels K, Galardy RE, Steinman L: Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 1994, 94:2177-2182
34. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990, 6:121-125
35. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrixdegrading proteinases. Proc Natl Acad Sci USA 1995, 92:402-406
36. Comabella M, Romera C, Camina M, Perkal H, Moro MA, Leza JC, Lizasoain I, Castillo M, Montalban X: TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis. J Neurol 2006, 253:701-706
37. Kieseier BC, Pischel H, Neuen-Jacob E, Tourtellotte WW, Hartung HP: ADAM-10 and ADAM-17 in the inflamed human CNS. Glia 2003, 42:398-405
38. Guo L, Eisenman JR, Mahimkar RM, Peschon JJ, Paxton RJ, Black RA, Johnson RS: A proteomic approach for the identification of cellsurface proteins shed by metalloproteases. Mol Cell Proteomics 2002, 1:30-36
39. Budagian V, Bulanova E, Orinska Z, Duitman E, Brandt K, Ludwig A, Hartmann D, Lemke G, Saftig P, Bulfone-Paus S: Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol Cell Biol 2005, 25:9324-9339
40. Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK: A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2007, 109:1026-1033
41. O'Bryan JP, Fridell YW, Koski R, Varnum B, Liu ET: The transforming receptor tyrosine kinase. Axl, is post-translationally regulated by proteolytic cleavage. J Biol Chem 1995, 270:551-557
42. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK: Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001, 411:207-211
43. D'Arcangelo D, Ambrosino V, Giannuzzo M, Gaetano C, Capogrossi MC: Axl receptor activation mediates laminar shear stress anti-apoptotic effects in human endothelial cells. Cardiovasc Res 2006, 71:754-763
44. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G: TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007, 131:1124-1136
45. Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv LB: Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 2006, 203:1891-1901
46. Raine CS: Multiple sclerosis: clinical and pathogenic basis. Edited by Raine CS, McFarland HF, Tourtellotte WW. Chapman & Hall Medical, 1997, pp 151-171
47. Lassmann H, Raine CS, Antel J, Prineas JW: Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 1998, 86:213-217
48. Cannella B, Raine CS: Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 2004, 55:46-57
49. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
50. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354
51. Zamora-Leon SP, Bresnick A, Backer JM, Shafit-Zagardo B: Fyn phosphorylates human MAP-2c on tyrosine 67. J Biol Chem 2005, 280:1962-1970
52. Cohen J, Cohen P: Applied multiple regression correlation analysis for the behavioral sciences. 2nd edition. Hillsdale, New Jersey: L. Erlbaum Associates, 1983, pp 25-78
53. Endres K, Anders A, Kojro E, Gilbert S, Fahrenholz F, Postina R: Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 2003, 270:2386-2393
54. Hoehn HJ, Kress Y, Sohn S, Brosnan C, Bourdon S, Shafit-Zagardo B: Axl-/-mice have delayed recovery and prolonged axonal damage following cuprizone toxicity. Brain Res 2008, 1240:1-11
55. Binder MD, Cate HS, Prieto AL, Kemper D, Butzkueven H, Gresle MM, Cipriani T, Jokubaitis VG, Carmeliet P, Kilpatrick TJ: Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J Neurosci 2008, 28:5195-5206
56. Kotter MR, Zhao C, van Rooijen N, Franklin RJ: Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 2005, 18:166-175
57. Zhao C, Fancy SP, Kotter MR, Li WW, Franklin RJ: Mechanisms of CNS remyelination the key to therapeutic advances. J Neurol Sci 2005, 233:87-91
58. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285
59. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A: The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 2004, 172:6362-6372
60. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F: Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci USA 2001, 98:5815-5820
61. Lopez-Perez E, Zhang Y, Frank SJ, Creemers J, Seidah N, Checler F: Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the prohormone convertase 7 and the disintegrin metalloprotease ADAM10. J Neurochem 2001, 76:1532-1539
62. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP: Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004, 164:769-779
63. Anders A, Gilbert S, Garten W, Postina R, Fahrenholz F: Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J 2001, 15:1837-1839
64. Yagami T, Ueda K, Asakura K, Sakaeda T, Nakazato H, Kuroda T, Hata S, Sakaguchi G, Itoh N, Nakano T, Kambayashi Y, Tsuzuki H: Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis. Neuropharmacology 2002, 43:1289-1296
65. Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK: Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J Immunol 2007, 178:5635-5642
66. Li R, Chen J, Hammonds G, Phillips H, Armanini M, Wood P, Bunge R, Godowski PJ, Sliwkowski MX, Mather JP: Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci 1996, 16:2012-2019